BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, November 14, 2025
See today's BioWorld MedTech
See today's BioWorld
Home
» Mallinckrodt wins FDA nod for regenerative skin therapy for burns
To read the full story,
subscribe
or
sign in
.
Mallinckrodt wins FDA nod for regenerative skin therapy for burns
June 16, 2021
By
Jennifer Boggs
More than four months after its original PDUFA date of Feb. 2, 2021, Mallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns.
BioWorld
BioWorld MedTech
Drugs
Medical devices and technologies
Regulatory
Dermatologic
BARDA
FDA
Priority review